ANCA vasculitis meets epigenetics - Closing in on the molecular roots of disease

Nephrology Dialysis Transplantation

Volumn 26, Issue 4, 2011, Pages 1146-1148

  Zeisberg, Michael ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; MESSENGER RNA; MYELOBLASTIN; MYELOPEROXIDASE; TRANSCRIPTION FACTOR RUNX3;

ANCA ASSOCIATED VASCULITIS; ARTICLE; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENE LOCUS; GENETIC VARIABILITY; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK FACTOR; SUMOYLATION; TRANSCRIPTION REGULATION;

ANIMALS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; EPIGENOMICS; HUMANS; VASCULITIS;

EID: 79953876715     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq834     Document Type: Article

References (19)

1. Hewagama A, Richardson B. The genetics and epigenetics of autoimmune diseases. J Autoimmun 2009; 33: 3-11
2. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003; 33 (Suppl): 245-254 (Pubitemid 36278835)
3. Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell 2007; 128: 669-681 (Pubitemid 46273573)
4. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128: 683-692 (Pubitemid 46273572)
5. Bechtel W, McGoohan S, Zeisberg EM et al. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med 2010; 16: 544-550
6. Ciavatta DJ, Yang J, Preston GA et al. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCAvasculitis. J Clin Invest 2010; 120: 3209-3219
7. Li E, Beard C, Jaenisch R. Role for DNA methylation in genomic imprinting. Nature 1993; 366: 362-365 (Pubitemid 23349366)
8. Fujita N, Shimotake N, Ohki I et al. Mechanism of transcriptional regulation by methyl-CpG binding protein MBD1. Mol Cell Biol 2000; 20: 5107-5118 (Pubitemid 30431564)
9. Wade PA. Methyl CpG binding proteins: coupling chromatin architecture to gene regulation. Oncogene 2001; 20: 3166-3173 (Pubitemid 32553572)
10. Soshnikova N, Duboule D. Epigenetic regulation of Hox gene activation: the waltz of methyls. Bioessays 2008; 30: 199-202 (Pubitemid 351341123)
11. Dambacher S, Hahn M, Schotta G. Epigenetic regulation of development by histone lysine methylation. Heredity 2010; 105: 24-37
12. Maunakea AK, Chepelev I, Zhao K et al. Epigenome mapping in normal and disease States. Circ Res 2010; 107: 327-339
13. Falk RJ, Jennette JC. ANCA disease: where is this field heading? J Am Soc Nephrol 2010; 21: 745-752
14. Yang JJ, Pendergraft WF, Alcorta DA et al. Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplas-mic autoantibody- associated glomerulonephritis. J Am Soc Nephrol 2004; 15: 2103-2114 (Pubitemid 39031349)
15. Li QL, Ito K, Sakakura C et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002; 109: 113-124 (Pubitemid 34327521)
16. Agger K, Cloos PA, Christensen J et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 2007; 449: 731-734 (Pubitemid 47552088)
17. De Santa F, Totaro MG, Prosperini E et al. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 2007; 130: 1083-1094 (Pubitemid 47410272)
18. Abdgawad M, Hellmark T, Gunnarsson L et al. Increased neutrophil membrane expression and plasma level of proteinase 3 in systemic vasculitis are not a consequence of the-564 A/G promotor polymorphism. Clin Exp Immunol 2006; 145: 63-70 (Pubitemid 43893934)
19. Goffin J, Eisenhauer E. DNA methyltransferase inhibitors-state of the art. Ann Oncol 2002; 13: 1699-1716